Kwanan nan, Sanxin Medical extracorporeal wurare dabam dabam bututu ta hanyar Amurka Food and Drug Administration (FDA) marketing izni (K202796), wannan shi ne na farko sanxin likita jini jerin kayayyakin samu FDA marketing izni (510K) !Shi ne na biyar samfur don samun FDA. (510K) marketing izini bayan kamfanin ta aminci sirinji, yarwa bakararre sirinji, IV catheter da likita mask.Sanxin Medical ya kuma zama na farko manufacturer na extracorporeal wurare dabam dabam Lines a kasar Sin don samun FDA (510K) marketing izni, wanda ya rufe mahara magani halaye na tsarkakewar jini (hemodialysis, hemofiltration, hemodiafiltration, hemoperfusion, da dai sauransu).A halin yanzu, akwai kasa da masana'antun 20 na layin kewayawa na waje a duk duniya waɗanda suka sami izinin tallan FDA.

An kafa shi a cikin 1997, Sanxin Medical babban kamfani ne na fasaha na ƙasa wanda ya kware a cikin bincike, haɓakawa, masana'anta, tallace-tallace da sabis na na'urorin likitanci.Bayan shekaru 20 na ci gaba, Sanxin Medical ya girma a matsayin babban mai samar da cikakkun hanyoyin amfani da hemodialysis a kasar Sin.Shi ne na farko a cikin masana'antu don ƙaddamar da tsarin kula da ingancin inganci na CE CMD da takaddun shaida na samfur. Amincewar nasarar FDA (510K) ya nuna cewa samfuran bututun hemodialysis na Sanxin Medical sun kasance daidai da matakin farko a duniya, kuma Har ila yau, wata shaida ce mai ƙarfi cewa tambarin kasar Sin ya sami damar shiga kasuwannin duniya da kuma karramawa.Sanxin Medical ya buɗe sabon zamani na gasar kasuwar duniya.

Sanxin Medical zai yi amfani da wannan damar don ci gaba da haɓaka dabarun ci gaban dabarun bincike na gida mai zaman kansa da haɓakawa da haɓaka haɗin gwiwa na duniya, kafaɗar manufar ci gaban kayan aikin likitanci na ƙasa, haɓaka ƙarin samfuran inganci ga duniya, samarwa marasa lafiya lafiya da inganci. - ingantattun kayayyaki da ayyuka, kuma suna ba da gudummawa ga haɓaka hanyoyin kiwon lafiya da kiwon lafiya na duniya.